Found: 18
Select item for more details and to access through your institution.
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 2, p. 398, doi. 10.3390/pharmaceutics14020398
- By:
- Publication type:
- Article
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14504, doi. 10.3390/ijms232314504
- By:
- Publication type:
- Article
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.983000
- By:
- Publication type:
- Article
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 8, p. 949, doi. 10.1038/s41587-021-00933-4
- By:
- Publication type:
- Article
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00821-3
- By:
- Publication type:
- Article
Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00786-9
- By:
- Publication type:
- Article
Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00577-8
- By:
- Publication type:
- Article
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1135815
- By:
- Publication type:
- Article
Ca<sub>V</sub>3.2 drives sustained burst‐firing, which is critical for absence seizure propagation in reticular thalamic neurons.
- Published in:
- Epilepsia (Series 4), 2018, v. 59, n. 4, p. 778, doi. 10.1111/epi.14018
- By:
- Publication type:
- Article
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00345-0
- By:
- Publication type:
- Article
Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation.
- Published in:
- Allergy, 2024, v. 79, n. 7, p. 1974, doi. 10.1111/all.16049
- By:
- Publication type:
- Article
Nucleoside‐modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens.
- Published in:
- Allergy, 2023, v. 78, n. 1, p. 315, doi. 10.1111/all.15527
- By:
- Publication type:
- Article
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 686, p. 1, doi. 10.1126/scitranslmed.abn3464
- By:
- Publication type:
- Article
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04555-1
- By:
- Publication type:
- Article
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17409-9
- By:
- Publication type:
- Article